Retatrutide
10mg vial
Triple-action GLP-1/GIP/Glucagon receptor agonist. Studied for metabolic optimization and appetite regulation.
$100.00 CAD
Search
Find compounds by name, research topic, or area of interest.
4 compounds
COA
Retatrutide
20mg vial
Triple-action GLP-1/GIP/Glucagon receptor agonist. Large research vial for extended protocols.
$150.00 CAD
Retatrutide
30mg vial
Triple-action GLP-1/GIP/Glucagon receptor agonist. Large 30mg research vial for extended metabolic protocols.
$240.00 CAD
Bundle
GLP-4 Blend
60mg vial
Retatrutide 20mg + Tirzepatide 40mg in one 60mg vial for combined incretin and metabolic research.
$240.00 CAD
Research
ingredients
·
Retatrutide: Understanding the Triple Receptor Agonist Mechanism
Retatrutide activates GLP-1, GIP, and glucagon receptors simultaneously. Here's what the Phase 2 trial data shows and why researchers are paying close attention.
10 min read
Read →